MoneyWorks4Me

USFDA inspects Cadila Healthcare’s formulations manufacturing facility at Baddi

09 Mar 2020 Evaluate

The US Food and Drug Administration (USFDA) has inspected Cadila Healthcare’s formulations manufacturing facility located at Baddi from March 2-9, 2020. This was a cGMP and Post Approval Inspection. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..